Chromosome 18 long arm deletion syndrome

From WikiMD's Medical Encyclopedia

Revision as of 15:03, 30 March 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Chromosome 18 long arm deletion syndrome, also known as 18q- syndrome, is a rare genetic disorder characterized by the deletion of part of the long arm (q arm) of chromosome 18. The condition is associated with a wide range of physical, developmental, and intellectual disabilities, with symptoms and severity varying significantly among affected individuals. The syndrome was first described in the medical literature in the 1960s, and since then, research has continued to uncover more about its manifestations, causes, and management strategies.

Symptoms and Characteristics[edit]

Individuals with Chromosome 18 long arm deletion syndrome may exhibit a variety of symptoms, which can vary widely in severity. Common characteristics include, but are not limited to, intellectual disability, growth retardation, hypotonia (decreased muscle tone), and distinctive facial features such as a prominent forehead, a high-arched palate, and a small jaw. Other possible features include hearing loss, vision problems, heart defects, and abnormalities of other organs. The range and severity of symptoms are influenced by the size and location of the deletion on chromosome 18.

Causes[edit]

Chromosome 18 long arm deletion syndrome is caused by a deletion of material on the long arm of chromosome 18. The exact reason why this deletion occurs is not fully understood, but it is known to happen randomly. There is no evidence to suggest that the condition is inherited or the result of environmental factors. The syndrome is typically diagnosed through genetic testing, which can identify the deletion on chromosome 18.

Diagnosis[edit]

Diagnosis of Chromosome 18 long arm deletion syndrome is primarily based on clinical evaluation and confirmed through genetic testing, such as karyotyping or fluorescence in situ hybridization (FISH). These tests can visualize the chromosomes and detect the presence of a deletion on chromosome 18. Early diagnosis is crucial for the management of the syndrome, as it allows for the initiation of supportive therapies and interventions.

Management and Treatment[edit]

There is no cure for Chromosome 18 long arm deletion syndrome, and treatment is symptomatic and supportive. Management strategies may include physical therapy, occupational therapy, speech therapy, and educational support to address developmental delays and intellectual disabilities. Regular follow-up with a team of specialists is important to monitor and treat the various health issues associated with the syndrome, such as heart defects, hearing loss, and vision problems.

Prognosis[edit]

The prognosis for individuals with Chromosome 18 long arm deletion syndrome varies depending on the severity of symptoms and the presence of congenital anomalies. With early intervention and supportive care, many individuals can lead fulfilling lives. However, the intellectual disability and health complications associated with the syndrome can pose significant challenges.

Research[edit]

Ongoing research is focused on better understanding the genetic mechanisms underlying Chromosome 18 long arm deletion syndrome, developing more effective management strategies, and improving the quality of life for affected individuals. Studies on the function of genes located on chromosome 18 and their role in development may provide insights into the syndrome and potential therapeutic targets.


Stub icon
   This article is a  stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.